CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
NET SALES
Net Sales	$ 16,958,240	$ 13,506,405
COST OF SALES	9,529,720	6,942,366
GROSS PROFIT	7,428,520	6,564,039
OPERATING EXPENSES
Selling expenses	1,439,412	1,262,502
General and administrative	3,194,631	3,881,847
Total Operating Expenses	4,634,043	5,144,349
INCOME FROM OPERATIONS	2,794,477	1,419,690
OTHER INCOME (EXPENSES)
Other income (expense)	(45,877)	98,901
Interest income	1,055	152
Interest expense	(89,036)	(89,201)
Total Other Income (Expenses), net	(133,858)	9,852
INCOME BEFORE INCOME TAX	2,660,619	1,429,542
INCOME TAX EXPENSE	(492,630)	(366,879)
NET INCOME INCLUDING NONCONTROLLING INTEREST	2,167,989	1,062,663
LESS: NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTEREST	(279,703)	(124,259)
NET INCOME ATTRIBUTABLE TO LINKWELL CORP	1,888,286	938,404
OTHER COMPREHENSIVE INCOME
Foreign currency translation	785,599	432,652
COMPREHENSIVE INCOME	2,673,885	1,371,056
BASIC AND DILUTED INCOME PER COMMON SHARE
Basic earnings per shares from continuing operation	$ 0.62	$ 0.33
Diluted earnings per shares from continuing operation	$ 0.62	$ 0.33
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	3,048,310	2,886,849
Diluted	3,048,310	2,886,849
All Other
NET SALES
Net Sales	7,685,380	6,517,018
Shanghai Jiuqing Pharmaceuticals Company, Ltd.
NET SALES
Net Sales	$ 9,272,860	$ 6,989,387